News shared by:

336 Articles
31 Mar 2019
Merck to invest in Swiss biologics production site

German healthcare company Merck has revealed plans to invest €150m to expand the capacity of its Swiss biotech medicines manufacturing site in Aubonne. Over the 2019-2023 period, this...

31 Mar 2019
AstraZeneca deal with Daiichi Sankyo for cancer drug development

The deal, which could reach amounts of up to $6.90 billion will involve both companies jointly developing Daiichi Sankyo’s antibody drug conjugate (ADC) [fam-]trastuzumab deruxtecan as a...

28 Mar 2019
Micronisation may be the answer to poor water solubility in drugs.

Over the past few everyday items such as computer chips and mobile phone batteries have been shrinking. Size reduction technology is also commonplace in drug development, where reducing the...

28 Mar 2019
Hong-Kong-based Lee’s Pharm and RegeneRx develop ophthalmic drug in China

US-based tissue regeneration-focused RegeneRx has announced it is accelerating the development of RGN-259 in China for a range of ophthalmic indications in collaboration with its partner...

26 Mar 2019
Purdue Pharma agrees to $270M with Oklahoma

Purdue Pharma, the OxyContin maker accused of helping spark and fuel the nation’s opioid epidemic, has reportedly agreed to pay $270 million to settle a lawsuit with Oklahoma. The...

26 Mar 2019
Thermo Fisher buys Brammer Bio for approximately $1.7bn

Thermo Fisher, another life sciences group pitching in on the future of gene therapy, has announced plans to enter into a definitive agreement to acquire Brammer Bio for approximately $1.7 billion....

Block ?

If this page is in your subscriptions, then it will be removed. You will not see this page. If you want to unblock a user, go to the settings, the list of blocked users and click unblock

Complain

The user will not know who exactly sent the complaint

Delete Company

The user will not know who exactly sent the complaint

Notifications

You Have 112 readed notifications

CHATS

Select chat category

×